Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112398372 | 11239837 | 2 | F | 201502 | 20160915 | 20150706 | 20160920 | PER | US-PFIZER INC-2015218280 | PFIZER | 45.00 | YR | M | Y | 98.00000 | KG | 20160920 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112398372 | 11239837 | 1 | PS | VIAGRA | SILDENAFIL CITRATE | 1 | Oral | 100 MG, AS NEEDED (100 MG, TABLET, ONE TIME) | U | A468101 | 20895 | 100 | MG | FILM-COATED TABLET | |||||
| 112398372 | 11239837 | 2 | SS | VIAGRA | SILDENAFIL CITRATE | 1 | U | 20895 | FILM-COATED TABLET | ||||||||||
| 112398372 | 11239837 | 3 | SS | CIALIS | TADALAFIL | 1 | 5 MG, DAILY | U | 0 | 5 | MG | ||||||||
| 112398372 | 11239837 | 4 | C | RANITIDINE. | RANITIDINE | 1 | Oral | 150 MG, 2X/DAY | 0 | 150 | MG | CAPSULE | BID | ||||||
| 112398372 | 11239837 | 5 | C | KETOTIFEN | KETOTIFEN | 1 | Ophthalmic | 1 GTT, 2X/DAY (OPHTH SOLN 5 ML) | 0 | 1 | GTT | BID | |||||||
| 112398372 | 11239837 | 6 | C | CYCLOBENZAPRINE | CYCLOBENZAPRINE | 1 | Oral | 10 MG, DAILY (2-3 TIMES EVERY DAY) | 0 | 10 | MG | TABLET | |||||||
| 112398372 | 11239837 | 7 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Oral | 1000 MG, AS NEEDED, (500 MG, TAKE 2 TABLET EVERY 8 HOURS) | 0 | 1000 | MG | TABLET | |||||||
| 112398372 | 11239837 | 8 | C | CETIRIZINE | CETIRIZINE HYDROCHLORIDE | 1 | Oral | 10 MG, DAILY | 0 | 10 | MG | TABLET | |||||||
| 112398372 | 11239837 | 9 | C | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | Oral | 100 MG, 1X/DAY, (BEDTIME AFTER MELS) | 0 | 100 | MG | TABLET | QD | ||||||
| 112398372 | 11239837 | 10 | C | MIRTAZAPINE. | MIRTAZAPINE | 1 | Oral | 45 MG, 1X/DAY, (1 TABLET EVEY BED TIME) | 0 | 45 | MG | TABLET | QD | ||||||
| 112398372 | 11239837 | 11 | C | TRUVADA | EMTRICITABINETENOFOVIR DISOPROXIL FUMARATE | 1 | Oral | UNK, DAILY (200 MG- 300 MG TABLET) | 0 | TABLET | |||||||||
| 112398372 | 11239837 | 12 | C | NORVIR | RITONAVIR | 1 | Oral | 100 MG, DAILY (TAKE 1 TABLET) | 0 | 100 | MG | TABLET | |||||||
| 112398372 | 11239837 | 13 | C | REYATAZ | ATAZANAVIR SULFATE | 1 | Oral | 300 MG, DAILY (WITH FOOD) | 0 | 300 | MG | CAPSULE | |||||||
| 112398372 | 11239837 | 14 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 500 MG, 2X/DAY, (EVERY MORNING AND EVENING WITH MEAL) | 0 | 500 | MG | TABLET | BID | ||||||
| 112398372 | 11239837 | 15 | C | CELEXA | CITALOPRAM HYDROBROMIDE | 1 | Oral | 40 MG, DAILY | 0 | 40 | MG | TABLET | |||||||
| 112398372 | 11239837 | 16 | C | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 10 MG, DAILY, (TAKE 1 TABLET) | 0 | 10 | MG | TABLET | |||||||
| 112398372 | 11239837 | 17 | C | REMERON | MIRTAZAPINE | 1 | Sublingual | 45 MG, DAILY | 0 | 45 | MG | DISPERSIBLE TABLET | |||||||
| 112398372 | 11239837 | 18 | C | BENZTROPINE | BENZTROPINE | 1 | Oral | 1 MG, 1X/DAY | 0 | 1 | MG | TABLET | QD | ||||||
| 112398372 | 11239837 | 19 | C | PRAVASTATIN. | PRAVASTATIN | 1 | Oral | 20 MG, 1X/DAY | 0 | 20 | MG | TABLET | QD | ||||||
| 112398372 | 11239837 | 20 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 20 MG, 1X/DAY | 0 | 20 | MG | TABLET | QD | ||||||
| 112398372 | 11239837 | 21 | C | COLACE | DOCUSATE SODIUM | 1 | Oral | 100 MG, 2X/DAY, (TAKE 1 CAPSULE) | 0 | 100 | MG | CAPSULE | BID | ||||||
| 112398372 | 11239837 | 22 | C | HALOPERIDOL. | HALOPERIDOL | 1 | Oral | 10 MG, 3X/DAY | 0 | 10 | MG | TABLET | TID | ||||||
| 112398372 | 11239837 | 23 | C | NAPROXEN. | NAPROXEN | 1 | Oral | 500 MG, 2X/DAY (WITH FOOD) | 0 | 500 | MG | TABLET | BID | ||||||
| 112398372 | 11239837 | 24 | C | SODIUM CHLORIDE. | SODIUM CHLORIDE | 1 | Nasal | UNK UNK, DAILY (2 SPRAY EACH NOSTRIL DAILY) | 0 | ||||||||||
| 112398372 | 11239837 | 25 | C | FLUTICASONE | FLUTICASONEFLUTICASONE PROPIONATE | 1 | Nasal | UNK, 50 MCG/ACTUATION (SPRAY 2 SPRAY BY INTRANASAL EVERY DAY FOR 5 DAYS IN EACH NOSTRIL) | 0 | NASAL SPRAY, SUSPENSION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 112398372 | 11239837 | 1 | Erectile dysfunction |
| 112398372 | 11239837 | 2 | Sexual dysfunction |
| 112398372 | 11239837 | 3 | Erectile dysfunction |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 112398372 | 11239837 | Drug ineffective | |
| 112398372 | 11239837 | Erection increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |